NCT07168291 2025-09-17Novel Bispecific AbTCR (Anti-CD19/CD22)-T Cells in Relapsed or Refractory B-cell LymphomaFirst Affiliated Hospital Xi'an Jiaotong UniversityPhase EARLY_PHASE1 Not yet recruiting3 enrolled